Tag Archives: sciencedaily

No link found between bladder cancer, use of pioglitazone or rosiglitazone, Avandia — ScienceDaily

Bladder cancer is the ninth most common cancer in the world, with 430,000 new cases diagnosed in 2012. Europe and North America have the highest incidence of bladder cancer, with an even higher incidence in people with diabetes. Bladder tumours overexpress a natural part of the cell machinery, a transcription factor in the cell nucleus known as ‘peroxisome proliferator-activated receptor gamma’ (or PPARγ) that is found in the urothelium (the lining of the urinary tract). Both pioglitazone and rosiglitazone are part of the thiazolidinediones (TZDs) class of drugs, which act as PPARγ agonists, meaning they induce the same action as PPARγ…

Smoking and higher mortality in men

Smoking is a risk factor for various diseases, not only lung cancer. Epidemiological data show that male smokers have a greater risk of developing cancer outside the respiratory tract than female smokers. In the present study, which is the result of an international collaboration, the researchers discovered an association between smoking and genetic damage among men that might explain this sex difference. ‘We have previously in 2014 demonstrated an association between loss of the Y chromosome in blood and greater risk for cancer…

Technology breakthrough reveals cellular transcription process

The technology is known as the “FISH investigation protocol” (Fluorescent in situ hybridization) — it optimises current flow cytometry processes, resulting in a greater visibility of the transcription of RNA, a key step in the transmission of cellular information. …

Mini chromosomes that strengthen tumors

Although scientists have known for about twenty years about double minutes, little chromosomal fragments which sometimes appear during cellular division, they have just started to understand their exact function. Due to replication errors, these mini-chromosomes lack centromere, which allows them to replicate extremely rapidly and autonomously. Scientists therefore suspect that they play a role in the development of cancers, diseases that are caused by mutations in genes that control cellular metabolism and development…

Cancer from asbestos caused by more than one cell mutation

Malignant mesothelioma is a rare form of cancer that affects the mesothelium — the protective lining that covers the internal organs, such as the lungs, the heart and the abdominal cavity. It is estimated that malignant mesothelioma affects up to 3,200 people in the USA each year, most of whom die within a year of diagnosis. The primary cause of this cancer is exposure to asbestos, which used to be used in building construction…

Chemotherapy can complicate immediate breast reconstruction after mastectomy — ScienceDaily

Chemotherapy is increasingly used to treat larger operable or advanced breast cancer prior to surgery. Chemotherapy delivered via the placement of a central venous line that remains in place for the duration of treatment can result in pre-operative thromboembolic events, which can require the administration of anticoagulation agents. This in turn can complicate subsequent surgery and is particularly significant when complex reconstruction is anticipated immediately following the mastectomy. “There is limited research on the impact of this complication on breast reconstruction pathways and guidance for optimal management of these patients,” notes Professor Charles M…

Why bowel cancer sometimes outsmarts treatment

Cancer Research UK scientists have discovered that bowel cancer may not be restricted to starting its journey in the stem cells in the lining of the intestines as previously thought. The researchers, based at the Wellcome Trust Centre for Human Genetics, studied a hereditary faulty gene which can cause bowel cancer in middle age. The faulty gene causes normal cells to behave like immortal stem cells and develop tumours of their own- challenging the theory that normal cells have a fixed fate and limited lifespan. The cells lining the bowel are continuously replaced — new ‘daughter’ cells are produced by immortal stem cells to replace those that have worn out. …

Men with life expectancies of less than 10 years still receive aggressive treatment for prostate cancer despite guidelines — ScienceDaily

In the first study to rigorously address prostate cancer treatment trends by life expectancy in a large, nationally representative sample, UCLA researchers found that more than half of prostate cancer patients 66 years and older have life expectancies of less than10 years, but half of those still were over-treated for their prostate cancer with surgery, radiation or brachytherapy, the implantation of radioactive seeds in the prostate. Randomized controlled studies have suggested that significant differences in survival between watchful waiting — monitoring the cancer closely but not treating it — and aggressive therapies don’t develop until 10 years after treatment. It only makes sense to not treat men expected to die of something else within 10 years…